Press Release|Articles|July 23, 2026

Priority Health Launches Cancer Support Solutions for Employers

Listen
0:00 / 0:00

Key Takeaways

  • Priority Health is deploying employer-selectable partnerships with Color Health and GRAIL to address rising cancer costs through navigation, guideline-based screening, and multi-cancer early detection strategies.
  • Color Health’s ASCO-certified Virtual Cancer Clinic provides oncologist-led, 50-state coverage spanning screening through survivorship, designed to close care gaps and reduce downstream cost escalation.
SHOW MORE

New Priority Health offerings address rising cancer rates and employer needs.

Grand Rapids, Michigan, July 22, 2026Priority Health, a nationally recognized health plan serving more than 1.4 million members, has launched 2 new cancer support solutions to help employers manage rising cancer-related costs for their employees, improve health outcomes, and provide proactive support across the cancer journey.

The National Institutes of Health forecasts a 34% increase in cancer spending by 2030, while cancer care already accounts for about 7% of total US health care spending. As a leading cause of death and disease in the US, cancer places a significant health and financial burden on patients, making early detection and navigation support critical.

“Employers are encountering significant financial exposure and workforce impact due to late-stage cancer diagnoses, which can increase treatment costs,” Chase Osbourne, senior vice president of employer solutions and innovation at Priority Health, said in a news release. “We’re offering these solutions in direct response to what our employer partners have told us—they need a way to control costs, support their employees, and drive better health outcomes. These new solutions deliver on all 3 fronts.”

The new solutions feature partnerships with 2 separate organizations: Color Health and its American Society of Clinical Oncology (ASCO)-certified Virtual Cancer Clinic for cancer navigation, support, and screening; and GRAIL for multi-cancer early detection, enabling employers to tailor offerings based on their workforce needs.

Color Health provides clinical, guidelines-concordant cancer care, from screening and early detection through active treatment and survivorship. Color’s oncologist-led, 50-state medical group establishes patient-provider relationships to enable clinical interventions that reduce cancer costs and significantly improve outcomes. Color drives 20% member engagement in year 1, leading to a 77% increase in screening adherence, 66% quicker time to diagnosis, and $62,000 in cost savings per patient. 

“Cancer remains one of the most challenging aspects of health care with younger diagnoses spiking, treatment costs rising sharply, and more survivors in the workplace than ever before,” Caroline Savello, president of Color, said in a news release. “Color drives measurable results through screening and early detection, along with proactive clinical interventions throughout treatment, working with Priority Health providers to close gaps and catch any missteps before they compound.”

GRAIL offers multi-cancer early detection through a blood test that screens for many cancer types, including cancers without recommended screenings.

“Too often, cancer is found only after symptoms appear, when treatment can be more complex, more costly, and less likely to lead to the best possible outcomes,” Megan Hall, PhD, vice president of medical affairs at GRAIL, said in a news release. “Priority Health is demonstrating leadership by bringing innovative cancer support solutions to employers, including access to the Galleri multi-cancer early detection test that can screen for many of the deadliest cancers before symptoms develop.

“Together, we are helping employers take a more proactive approach to cancer care — one that has the potential to support earlier detection when curative treatment options may be available, improve the employee experience, and address the growing burden cancer places on individuals, families, and the health care system,” she added.

Priority Health’s cancer support solutions are available for large self-funded employers to add to their Priority Health plan for a January 1, 2027, effective date. Learn more at priorityhealth.com.

About Priority Health

Our members are at the heart of everything we do. With 40 years in business, Priority Health is the second-largest health plan in Michigan and the third-largest provider-sponsored health plan in the nation, offering an extensive portfolio of health benefits options for employer groups and individuals, including Medicare and Medicaid plans.

Serving 1.4 million members in Michigan, Indiana, Ohio, and Wisconsin, Priority Health offers a broad network of primary care physicians and continues to be recognized as a leader for quality, customer service, transparency, and product innovation. Learn more about affordable, quality health coverage options from Priority Health. Visit the Priority Health newsroom for the latest news.

About Color Health

Color's Virtual Cancer Clinic, powered by Color Medical's 50-state, oncologist-led medical group, has transformed cancer care for employers, health plans, unions, and the public sector. Combining technology and artificial intelligence with a fully integrated medical group, Color's ASCO-certified virtual clinic broadens access to best-in-class care and lowers costs by avoiding late-stage diagnoses. Color identifies high-risk members, detects cancer earlier through guidelines-based screening, improves outcomes for patients in active treatment, and fully supports the unique needs of cancer survivors.

Connect with Color on LinkedIn, X, and Color.com.

About GRAIL

GRAIL is a health care company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages.

GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment, and recurrence monitoring.

GRAIL is headquartered in Menlo Park, California, with locations in Washington, DC, North Carolina, and the UK. For more information, visit grail.com.